Results 121 to 130 of about 17,710 (254)
Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema
This study performed an unbiased molecular profiling of CHE patients across diverse etiologies to identify shared pathogenic drivers and evaluate the impact of IL‐4Rα blockade via dupilumab over 16 weeks. CHE shows a mixed immune signature involving type 1, 2, and 3 pathways with features of atopic dermatitis and psoriasis.
Perrine Gery +25 more
wiley +1 more source
Dupilumab‐Associated Palmar Erythema Successfully Treated With Fluconazole
Australasian Journal of Dermatology, EarlyView.
Katina J. Selvaraj, Geoffrey Lee
wiley +1 more source
Codfish Oral Immunotherapy in Children Aged 2–10: Randomized Placebo‐Controlled Study
Codfish OIT significantly increased desensitization in children with fish allergy (43% vs. 11% placebo, p = 0.003), with 69% achieving 10‐fold threshold increases versus 26% in placebo (p = 0.0003). Sustained unresponsiveness remained limited (23% vs. 9%, p = 0.332). Treatment demonstrated acceptable safety with predominantly mild reactions and reduced
Agnes Sze‐yin Leung +9 more
wiley +1 more source
A Case for Anti‐IgE Vaccination
ABSTRACT Immunoglobulin E (IgE) plays a central role in allergic diseases by binding to the high‐affinity receptor FcεRI on mast cells and basophils, where allergen‐induced crosslinking triggers potent inflammatory responses. Various mechanisms by which IgE responses are generated and functionally regulated remain elusive despite many years of research.
Paul Engeroff +3 more
wiley +1 more source
Introduction Dupilumab and lebrikizumab have demonstrated efficacy in atopic dermatitis (AD) clinical trials; however, no direct comparisons exist. Methods Efficacy outcome achievement (dupilumab and lebrikizumab with topical corticosteroids [TCS]) at 16
Sonja Ständer +11 more
doaj +1 more source
Chinese Position Paper on Biologic Therapy for Allergic Rhinitis
ABSTRACT Allergic rhinitis (AR) is a common, persistent nasal disorder that poses significant public health challenges worldwide. Current treatment options frequently fail to achieve adequate symptom control in a substantial subset of patients. Over the past two decades, biologic therapies that target type 2 inflammatory pathways have been used to ...
Yuan Zhang +37 more
wiley +1 more source
Pronóstico y evolución de la rinosinusitis crónica poliposa intervenida mediante cirugía endoscópica nasosinusal según fenotipos y endotipos [PDF]
Se realiza un estudio observacional de seguimiento desarrollado en el Hospital Clínico Universitario de Valladolid. La muestra consta de 20 pacientes intervenidos de rinosinusitis crónica poliposa mediante cirugía endoscópica nasosinusal (CENS) entre ...
Rivas González, Juan
core
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. It usually develops in childhood and may persist into adulthood. Dupilumab is a fully human monoclonal antibody directed against interleukin-4R-alpha, the common chain ...
Jing Zhang +4 more
doaj +1 more source
Association Between Biologic Therapy and Reduced Acute Rhinosinusitis Episodes: A Retrospective Database Study [PDF]
In the control group, 14% experienced at least one episode of ABRS. In the biologic‐exposed group, only 6% had an ABRS episode. This difference was shown to be statistically significant, reflecting a strong protective association biologics have on ABRS episodes.
Zheng W +4 more
europepmc +2 more sources

